November 25, 2025 · Form 4 insider transaction
Almstead Neil Gregory bought 8,410 shares of PTC Therapeutics Inc at $18.01 per share, a transaction worth $151.5K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on December 10, 2024.